Literature DB >> 25576993

The primary open-angle african american glaucoma genetics study: baseline demographics.

Emily S Charlson1, Prithvi S Sankar1, Eydie Miller-Ellis1, Meredith Regina1, Raymond Fertig1, Julia Salinas1, Maxwell Pistilli1, Rebecca J Salowe1, Allison L Rhodes1, William T Merritt1, Michael Chua1, Benjamin T Trachtman1, Harini V Gudiseva1, David W Collins1, Venkata Ramana Murthy Chavali1, Charles Nichols1, Jeffrey Henderer2, Gui-Shuang Ying1, Rohit Varma3, Eric Jorgenson4, Joan M O'Brien5.   

Abstract

PURPOSE: To describe the baseline characteristics of the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study cohort, the largest African American population with primary open-angle glaucoma (POAG) recruited at a single institution (University of Pennsylvania [UPenn], Department of Ophthalmology, Scheie Eye Institute) to date.
DESIGN: Population-based, cross-sectional, case-control study. PARTICIPANTS: A total of 2520 African American subjects aged 35 years or more who were recruited from the greater Philadelphia, Pennsylvania area.
METHODS: Each subject underwent a detailed interview and eye examination. The interview assessed demographic, behavioral, medical, and ocular risk factors. Current ZIP codes surrounding UPenn were recorded and US census data were queried to infer socioeconomic status. The eye examination included measurement of visual acuity (VA) and intraocular pressure, and a detailed anterior and posterior segment examination, including gonioscopy, dilated fundus and optic disc examination, visual fields, stereo disc photography, optical coherence tomography, and measurement of central corneal thickness. MAIN OUTCOME MEASURES: The baseline characteristics of gender, age, and glaucoma diagnosis were collected. Body mass index (BMI), hypertension, diabetes, alcohol and tobacco use, ocular conditions (including blindness, cataract, nonproliferative diabetic retinopathy, and age-related macular degeneration), and use of ocular medication and surgery were examined. Median population density, income, education level, and other socioeconomic measures were determined for the study cohort.
RESULTS: Of the 2520 African Americans recruited to the POAAGG study to date, 2067 (82.0%), including 807 controls and 1260 POAG cases, met all inclusion criteria and completed the detailed clinical ocular examination. Cases were more likely to have a lower BMI (P < 0.01) and report a history of blindness (VA of ≤20/200; P < 0.001), whereas controls were more likely to have diabetes (P < 0.001), have nonproliferative diabetic retinopathy (P = 0.02), and be female (P < 0.001). Study participants were drawn largely from predominantly African American neighborhoods of low income, high unemployment, and lower education surrounding UPenn.
CONCLUSIONS: The POAAGG study has currently recruited more than 2000 African Americans eligible for a POAG genetics study. Blindness and low BMI were significantly associated with POAG. This population was predominantly recruited from neighborhoods whose population income exists at or near the federal poverty level.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25576993      PMCID: PMC4372490          DOI: 10.1016/j.ophtha.2014.11.015

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  41 in total

1.  The validity of self-reported use of health care across socioeconomic strata: a comparison of survey and registration data.

Authors:  S A Reijneveld; K Stronks
Journal:  Int J Epidemiol       Date:  2001-12       Impact factor: 7.196

2.  Replication validity of genetic association studies.

Authors:  J P Ioannidis; E E Ntzani; T A Trikalinos; D G Contopoulos-Ioannidis
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

3.  Risk factors for open-angle glaucoma: a case-control study.

Authors:  D K Kaimbo; F Buntinx; L Missotten
Journal:  J Clin Epidemiol       Date:  2001-02       Impact factor: 6.437

4.  Self-reports of health care utilization compared to provider records.

Authors:  P L Ritter; A L Stewart; H Kaymaz; D S Sobel; D A Block; K R Lorig
Journal:  J Clin Epidemiol       Date:  2001-02       Impact factor: 6.437

5.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

Authors:  Kirk E Lohmueller; Celeste L Pearce; Malcolm Pike; Eric S Lander; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

6.  Functional health literacy and the risk of hospital admission among Medicare managed care enrollees.

Authors:  David W Baker; Julie A Gazmararian; Mark V Williams; Tracy Scott; Ruth M Parker; Diane Green; Junling Ren; Jennifer Peel
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

Review 7.  Primary open-angle glaucoma.

Authors:  Robert N Weinreb; Peng Tee Khaw
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

8.  Temba glaucoma study: a population-based cross-sectional survey in urban South Africa.

Authors:  Alan P Rotchford; James F Kirwan; Michael A Muller; Gordon J Johnson; Paul Roux
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

9.  The Los Angeles Latino Eye Study: design, methods, and baseline data.

Authors:  Rohit Varma; Sylvia H Paz; Stanley P Azen; Ronald Klein; Denise Globe; Mina Torres; Chrisandra Shufelt; Susan Preston-Martin
Journal:  Ophthalmology       Date:  2004-06       Impact factor: 12.079

Review 10.  A comprehensive review of genetic association studies.

Authors:  Joel N Hirschhorn; Kirk Lohmueller; Edward Byrne; Kurt Hirschhorn
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822

View more
  35 in total

1.  Association between Primary Open-Angle Glaucoma and Cognitive Impairment as Measured by the Montreal Cognitive Assessment.

Authors:  Makayla McCoskey; Victoria Addis; Kendall Goodyear; Prithvi S Sankar; Gui-Shuang Ying; Yinxi Yu; Rebecca Salowe; Qi N Cui; Eydie Miller-Ellis; Maureen Maguire; Joan M O Apos Brien
Journal:  Neurodegener Dis       Date:  2019-03-20       Impact factor: 2.977

2.  Factors associated with participation by African Americans in a study of the genetics of glaucoma.

Authors:  Rupin Parikh; Laura O'Keefe; Rebecca Salowe; Makayla Mccoskey; Wei Pan; Prithvi Sankar; Eydie Miller-Ellis; Victoria Addis; Amanda Lehman; Maureen Maguire; Joan O'Brien
Journal:  Ethn Health       Date:  2017-07-01       Impact factor: 2.772

3.  The African Descent and Glaucoma Evaluation Study (ADAGES) III: Contribution of Genotype to Glaucoma Phenotype in African Americans: Study Design and Baseline Data.

Authors:  Linda M Zangwill; Radha Ayyagari; Jeffrey M Liebmann; Christopher A Girkin; Robert Feldman; Harvey Dubiner; Keri A Dirkes; Matthew Holmann; Eunice Williams-Steppe; Naama Hammel; Luke J Saunders; Suzanne Vega; Kevin Sandow; Kathryn Roll; Rigby Slight; Daniel Auerbach; Brian C Samuels; Joseph F Panarelli; John P Mitchell; Lama A Al-Aswad; Sung Chul Park; Celso Tello; Jeremy Cotliar; Rajendra Bansal; Paul A Sidoti; George A Cioffi; Dana Blumberg; Robert Ritch; Nicholas P Bell; Lauren S Blieden; Garvin Davis; Felipe A Medeiros; Maggie C Y Ng; Swapan K Das; Nicholette D Palmer; Jasmin Divers; Carl D Langefeld; Barry I Freedman; Donald W Bowden; Mark A Christopher; Yii-der I Chen; Xiuqing Guo; Kent D Taylor; Jerome I Rotter; Robert N Weinreb
Journal:  Ophthalmology       Date:  2018-02-01       Impact factor: 12.079

Review 4.  Major review: Molecular genetics of primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2017-05-10       Impact factor: 3.467

5.  Non-physician grader reliability in measuring morphological features of the optic nerve head in stereo digital images.

Authors:  Victoria Addis; Enny Oyeniran; Ebenezer Daniel; Rebecca Salowe; Richard Zorger; Roy Lee; Maxwell Pistilli; Maureen Maguire; Qi Cui; Eydie Miller-Ellis; Joan M O'Brien; Prithvi S Sankar
Journal:  Eye (Lond)       Date:  2019-01-11       Impact factor: 3.775

6.  The association of mitochondrial DNA haplogroups with POAG in African Americans.

Authors:  Harini V Gudiseva; Maxwell Pistilli; Rebecca Salowe; Larry N Singh; David W Collins; Brian Cole; Jie He; Sayaka Merriam; Naira Khachataryan; Jeffrey Henderer; Victoria Addis; Qi N Cui; Prithvi S Sankar; Eydie Miller-Ellis; Venkata R M Chavali; Gui-Shuang Ying; Douglas Wallace; Joan M O'Brien
Journal:  Exp Eye Res       Date:  2019-01-15       Impact factor: 3.467

Review 7.  Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma.

Authors:  Ian D Danford; Lana D Verkuil; Daniel J Choi; David W Collins; Harini V Gudiseva; Katherine E Uyhazi; Marisa K Lau; Levi N Kanu; Gregory R Grant; Venkata R M Chavali; Joan M O'Brien
Journal:  Prog Retin Eye Res       Date:  2017-02-20       Impact factor: 21.198

8.  Family History in the Primary Open-Angle African American Glaucoma Genetics Study Cohort.

Authors:  Joan M O'Brien; Rebecca J Salowe; Raymond Fertig; Julia Salinas; Maxwell Pistilli; Prithvi S Sankar; Eydie Miller-Ellis; Amanda Lehman; Windell H A Murphy; Melissa Homsher; Katelyn Gordon; Gui-Shuang Ying
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

9.  Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population.

Authors:  Alexander Pleet; Melanie Sulewski; Rebecca J Salowe; Raymond Fertig; Julia Salinas; Allison Rhodes; William Merritt Iii; Vikas Natesh; Jiayan Huang; Harini V Gudiseva; David W Collins; Venkata Ramana Murthy Chavali; Paul Tapino; Amanda Lehman; Meredith Regina-Gigiliotti; Eydie Miller-Ellis; Prithvi Sankar; Gui-Shuang Ying; Joan M O'Brien
Journal:  Ophthalmic Epidemiol       Date:  2016-06-27       Impact factor: 1.648

10.  The role of ophthalmology departments in overcoming health care disparities.

Authors:  Rebecca J Salowe; Prithvi Sankar; Eydie Miller-Ellis; Maxwell Pistilli; Gui-Shuang Ying; Joan M O'Brien
Journal:  J Epidemiol Res       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.